A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer
Abstract Background Cancer-initiating cell (CIC), a functionally homogeneous stem-like cell population, is resonsible for driving the tumor maintenance and metastasis, and is a source of chemotherapy and radiation-therapy resistance within tumors. Targeting CICs self-renewal has been proposed as a t...
Main Authors: | Jinhua Wang, Yajing Xing, Yingying Wang, Yundong He, Liting Wang, Shihong Peng, Lianfang Yang, Jiuqing Xie, Xiaotao Li, Wenwei Qiu, Zhengfang Yi, Mingyao Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1392-8 |
Similar Items
-
Targeting BMI-1-mediated epithelial–mesenchymal transition to inhibit colorectal cancer liver metastasis
by: Zhiyao Xu, et al.
Published: (2021-05-01) -
Longitudinal associations between BMI change and the risks of colorectal cancer incidence, cancer-relate and all-cause mortality among 81,388 older adults
by: Ji-Bin Li, et al.
Published: (2019-11-01) -
Novel <i>SFRP2</i> DNA Methylation Profile Following Neoadjuvant Therapy in Colorectal Cancer Patients with Different Grades of BMI
by: Amanda Cabrera-Mulero, et al.
Published: (2019-07-01) -
Evaluation of Effective Factors in Incidence of Colorectal Cancer
by: Farhad Pourfarzi, et al.
Published: (2012-11-01) -
Prognostic significance of combined pretreatment body mass index (BMI) and BMI loss in patients with esophageal cancer
by: Gu WS, et al.
Published: (2019-04-01)